EUVIMEDEUVIMED entdecken
VergleichsstudieBeobachtungsstudieOpen Access · CC BY 4.0

Dexmedetomidine Versus Midazolam for Propofol Sparing in Procedural Sedation of Children With Leukemia: A Consecutive Case Series

Domenica Squillaci, Karen Console iD, Lara Colussi, Valentina Kiren, Marco Rabusin, Gabriele Stocco, Antonella Longo, Paolo Dalena iD, Egidio Barbi iD

Acta Anaesthesiologica Scandinavica · 2025-09 · 69 (8)

DOI: 10.1111/aas.70107 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Acta Anaesthesiologica Scandinavica, online erschienen am 31.07.2025. Verfasst von Domenica Squillaci und 8 weiteren Autor:innen. Beteiligte Einrichtung: University of Trieste, Trieste, Italy. Hauptthemen laut MEDLINE: Dexmedetomidine, Midazolam, Procedural Pain, Propofol. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Health, through the contribution given to the Institute for Maternal and Child Health IRCCS Burlo Garofolo, Trieste - Italy, Ministero della Salute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Propofol is commonly used in procedural sedation in oncology due to its rapid sedative effect and favorable recovery profile. However, several preclinical and clinical studies have demonstrated a dose‐dependent neurotoxic effect of this drug. Dexmedetomidine and midazolam are potential adjuvants that, if used as premedication, could reduce the required dose of propofol. This study compares the use of dexmedetomidine and midazolam in terms of propofol dose reduction during procedural sedation in oncology patients.

Methods

This one‐year retrospective study compared the outcomes of procedural sedation, in terms of propofol‐sparing, in 24 pediatric oncology patients who received midazolam (MP group, 52 procedures) or dexmedetomidine (DP group, 51 procedures) as premedication combined with propofol during bone marrow aspiration and/or lumbar puncture procedures. Data on propofol dosage, awakening time, vital parameters, and adverse events were examined.

Results

Premedication with dexmedetomidine was associated with a significantly lower dose of propofol than midazolam (2.51 vs. 4.00 mg/kg, p < 0.001). Wake‐up times were longer in the DP group (92 vs. 65 min; p = 0.045). Adverse events were very rare in both groups.

Conclusions

Dexmedetomidine demonstrates superior propofol‐sparing effects compared to midazolam, although it requires longer recovery times. These results support dexmedetomidine as a promising alternative in sedation protocols in pediatric oncology. Editorial Comment This retrospectively analysis of a single center series compared procedural sedation strategies for children involving propofol after standardized intravenous premedication with dexmedetomidine or midazolam. The findings demonstrated that dexmedetomidine in those doses and in combination with propofol confirmed sedative potency and duration more than that of the chosen midazolam premedication dosing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DexmedetomidineMidazolamProcedural PainPropofolPremedicationLeukemiaProcedural SedationDose-Response Relationship, DrugAdjuvants, AnesthesiaRetrospective StudiesSpinal PunctureBiopsy, NeedleTime FactorsInfusions, IntravenousHumansChildBone MarrowHypnotics and Sedatives

Stichwörter der Autor:innen

childrendexmedetomidineoncologysedation

Substanzen

DexmedetomidineMidazolamPropofolAdjuvants, AnesthesiaHypnotics and Sedatives

Autor:innen und Institutionen

  • University of Trieste, Trieste, Italy.
  • Institute for Maternal and Child Health, IRCCS "Burlo Garofolo", Trieste, Italy.

ORCID-Profile: Karen Console, Paolo Dalena, Egidio Barbi

Förderung

  • Italian Ministry of Health, through the contribution given to the Institute for Maternal and Child Health IRCCS Burlo Garofolo, Trieste - Italy
  • Ministero della Salute

Zitieren

APA

Squillaci, D., Console, K., Colussi, L., Kiren, V., Rabusin, M., Stocco, G., Longo, A., Dalena, P., & Barbi, E. (2025). Dexmedetomidine Versus Midazolam for Propofol Sparing in Procedural Sedation of Children With Leukemia: A Consecutive Case Series. Acta Anaesthesiologica Scandinavica, 69(8). https://doi.org/10.1111/aas.70107

Vancouver

Squillaci D, Console K, Colussi L, Kiren V, Rabusin M, Stocco G, et al. Dexmedetomidine Versus Midazolam for Propofol Sparing in Procedural Sedation of Children With Leukemia: A Consecutive Case Series. Acta Anaesthesiologica Scandinavica. 2025;69(8). doi:10.1111/aas.70107

BibTeX
@article{Squillaci2025,
  author = {Squillaci, Domenica and Console, Karen and Colussi, Lara and Kiren, Valentina and Rabusin, Marco and Stocco, Gabriele and Longo, Antonella and Dalena, Paolo and Barbi, Egidio},
  title = {Dexmedetomidine Versus Midazolam for Propofol Sparing in Procedural Sedation of Children With Leukemia: A Consecutive Case Series},
  journal = {Acta Anaesthesiologica Scandinavica},
  year = {2025},
  volume = {69},
  number = {8},
  doi = {10.1111/aas.70107}
}
Kostenlos starten →